IART today
$14.35-$0.42 (-2.84%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bearish
1 hourSymmetric Triangle
15 minStrong Bullish
5 minStrong Bearish
Daily trend turns up above $14.28
Key levels
Resistance$16.77
Resistance$15.25
Support$14.28
Support$13.31
Latest news & SEC filings
AnalystUBS kept its Neutral rating on Integra LifeSciences (IART) and lowered its price target to $14 from $19.
AnalystTruist Securities kept its Hold rating on Integra LifeSciences (IART) and lowered its price target to $13 from $15.
AnalystCiti kept its Neutral rating on Integra LifeSciences (IART) and lowered its price target to $14 from $19.
All IART news →About Integra LifeSciences
Integra LifeSciences is a medical device maker focused on neurosurgery, reconstructive surgery, and wound care. It sells implants and instruments for tissue repair, including grafts made from animal-derived collagen, along with devices used in head and spine procedures. Customers are hospitals, clinics, and surgeons, and the company operates across the United States, Europe, and parts of Asia and Latin America.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
What Is the Price Target for IART?
SEPT Low Target
$15.30
SEPT Mid Target
$18.00
SEPT High Target
$20.70
Analyst Consensus
$18.00
Is IART a Buy or Sell Right Now?
Thesis
- •Revenue growing 1.5% YoY with SLOWING trend — consistent growth.
- •SEC filings signal active product innovation — 4 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for IART.
Start Free Trial →Is IART Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$24.03
8
Moat Score
NONE
5/9
Piotroski Score
0.6
Altman Z-Score
What Is Smart Money Doing with IART?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Veillon-Berteloot Chantal | officer | Sale | 1,455 | $24K | Sep 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →IART Growth Story
Revenue YoY
1.5%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-7388.89%
FCF Growth YoY
-224.4%
Revenue Trend
SLOWING
Dark Pool Trades for IART
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for IART, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:06:50 | $14.35 | 81,551 | $$1.2M | BUY |
| 21:00:29 | $14.35 | 4,004 | $$57K | BUY |
| 21:00:00 | $14.35 | 2,802 | $$40K | SELL |
| 20:59:06 | $14.32 | 3,505 | $$50K | MIDPOINT |
| 20:58:40 | $14.30 | 5,690 | $$81K | MIDPOINT |
5 dark pool trades shown · $$1.4M preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About IART
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for IART. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
SEPT Brain on $IART -- Bearish IART pulling back — down 5% from $18.92. Day range $17.90-$18.64. Last candle: doji (70% buying). Price in middle of zone $17.50-$18.30 — direction unclear, stop too wi...
Join 3,500+ traders discussing IART in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →IART — frequently asked questions
What is IART stock price today?
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) is at $14.35, down 2.84% (-$0.42) at the Nov 12, 2026 close.
Why is IART stock moving today?
Latest IART news — Oct 27, 2026: UBS kept its Neutral rating on Integra LifeSciences (IART) and lowered its price target to $14 from $19. · Oct 26, 2026: Truist Securities kept its Hold rating on Integra LifeSciences (IART) and lowered its price target to $13 from $15.
What is the IART price target?
The average analyst price target for IART is $18.00, ranging from $15 to $19, based on 5 analysts. Latest: Truist Securities maintains on Oct 14, 2026.
What do analysts rate IART?
Analyst ratings for IART: 0 Buy, 9 Hold, 1 Sell — consensus Hold.
Did IART beat earnings?
IART last reported on Jul 29, 2026: EPS $0.56 vs $0.48 expected — a beat of 16.7%.
Does IART pay a dividend?
IART does not currently pay a dividend.
How much debt does IART have?
INTEGRA LIFESCIENCES HOLDINGS CORP reported $707M of debt and $214M of cash (Jun 30, 2026).
What are IART support and resistance levels?
Support: $14.28, $13.31, $11.57. Resistance: $15.25, $16.77, $18.05.
What are insiders doing with IART?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on IART?
Oct 27, 2026: UBS kept its Neutral rating on Integra LifeSciences (IART) and lowered its price target to $14 from $19. · Oct 26, 2026: Truist Securities kept its Hold rating on Integra LifeSciences (IART) and lowered its price target to $13 from $15. · Oct 22, 2026: Citi kept its Neutral rating on Integra LifeSciences (IART) and lowered its price target to $14 from $19.